US medtech firm Terumo Blood and Cell Technologies has appointed Liza Loidolt as general manager of its cell and gene therapy business, marking a sharper strategic push into advanced therapeutics.
Summary Cyber tensions between the United States and China show Microsoft’s central yet fragile role in global cybersecurity, where its platforms serve as both assets and targets. While both ...
How-To Geek on MSN
Microsoft Excel isn't a database, please stop using it like one
Excel offers no such constraint. If someone is determined to enter bad data, they can simply paste values over a validated ...
Stars Insider on MSN
Lake Kaindy: the sunken forest born from an earthquake
Lake Kaindy, sunk deep within Kolsai Lakes National Park in Kazakhstan, is a natural landmark that was created out of a ...
Cryptopolitan on MSN
North Korea’s Konni group weaponizes Google’s Find Hub to steal logins
The North Korean hacker group Konni has discovered a new set of attacks that, for the first time, use Google's Find Hub asset ...
The North Korea-affiliated threat actor known as Konni (aka Earth Imp, Opal Sleet, Osmium, TA406, and Vedalia) has been attributed to a new set of attacks targeting both Android and Windows devices ...
There were no meetings, no memos, and no consultations when the system was introduced—only a training session and the unspoken expectation that any lull needed explaining. “Especially working from ...
Company reports Q3 2025 AUCATZYL® net product revenue of $21.1 million and deferred revenue of $7.6 million; 60 authorized treatment centers achieved ahead of targetClinical execution and data ...
4don MSN
London’s domestic abuse hotspots revealed by interactive map as killings rocket 60% in the capital
Campaigners describe Standard’s investigation as ‘staggering’ and call for systemic changes to justice system to protect ...
Learn how simple digital tools can organize your farm records, making information accessible when needed for budgeting and ...
An interesting thing struck me as I listened to a range of Google execs unveil a slew of new business and enterprise focused announcements at their ...
First anticipated ZEVASKYN® patient treatment shifted to 4Q 2025 following implementation of optimized release assay -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results